Internal Medicine, Rheumatology · Hewlett, NY
NPI
1386969418
Since 2010
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
1157 Broadway
Hewlett, NY, 11557
Phone (516) 295-4481
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.9M
262,070 services
Medicare patients, 2024
652
Average age 75
Drug cost, 2024
$923K
3,153 prescriptions
Company payments, 2025
$4,954
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jordan E Brodsky was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 48,600 times for 23 patients. In total Jordan E Brodsky billed 262,070 services in 140 codes, and Medicare paid $2.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 48,600 | 23 | $3.63 | $177K |
| J0897 Injection, denosumab, 1 mg | Office | 26,400 | 277 | $20.50 | $541K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 16,001 | 128 | $0.10 | $1,633 |
| J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 14,952 | 22 | $0.38 | $5,746 |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 14,910 | 14 | $8.39 | $125K |
| 86235 Immunoassay | Office | 7,759 | 561 | $17.57 | $136K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 7,459 | 25 | $24.92 | $186K |
| J7329 Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 5,626 | 47 | $5.50 | $31K |
| 82784 Immunoassay | Office | 2,824 | 567 | $9.11 | $26K |
| 83516 Immunoassay | Office | 2,252 | 487 | $11.30 | $25K |
| 86147 Immunoassay | Office | 2,223 | 551 | $24.94 | $55K |
| 86146 Immunoassay | Office | 2,223 | 551 | $24.94 | $55K |
| 83521 Immunoassay | Office | 1,870 | 568 | $16.93 | $32K |
| 99214 Office E&M - Established | Office | 1,811 | 623 | $109.51 | $198K |
| 86160 Immunoassay | Office | 1,784 | 562 | $11.76 | $21K |
By year: 2022 $2.5M for 225,944 services; 2023 $2.7M for 260,040 services; 2024 $2.9M for 262,070 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 7,759 | 561 | $17.57 | $136K |
| 82784 Immunoassay | 2,824 | 567 | $9.11 | $26K |
| 83516 Immunoassay | 2,252 | 487 | $11.30 | $25K |
| 86146 Immunoassay | 2,223 | 551 | $24.94 | $55K |
| 86147 Immunoassay | 2,223 | 551 | $24.94 | $55K |
| 83521 Immunoassay | 1,870 | 568 | $16.93 | $32K |
| 86160 Immunoassay | 1,784 | 562 | $11.76 | $21K |
| 36415 Venipuncture Blood Collection | 1,649 | 620 | $8.64 | $14K |
| 85025 Blood Count | 1,647 | 619 | $7.60 | $13K |
| 83615 Clinical Chemistry | 1,643 | 618 | $5.92 | $9,727 |
Medicare prescription drug claims, 2024
In 2024, the drug Jordan E Brodsky prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 559 prescriptions and refills. In total Jordan E Brodsky wrote 3,153 Medicare prescriptions that cost $923K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 559 | 1,530 | 194 | $23K |
| Meloxicam Generic | 322 | 550 | 116 | $1,565 |
| Methylprednisolone Generic | 254 | 294 | 133 | $3,590 |
| Sulfasalazine Generic | 174 | 416 | 57 | $5,229 |
| Tizanidine Hcl Generic | 169 | 309 | 85 | $2,057 |
| Gabapentin Generic | 163 | 250 | 42 | $1,966 |
| Prednisone Generic | 126 | 247 | 36 | $1,549 |
| Leflunomide Generic | 123 | 319 | 44 | $13K |
| Duloxetine Hcl Generic | 105 | 267 | 32 | $1,654 |
| Methotrexate Methotrexate Sodium | 86 | 220 | 24 | $2,952 |
| Cyclobenzaprine Hcl Generic | 83 | 99 | 22 | $847 |
| Tramadol Hcl Generic | 83 | 83 | 21 | $882 |
| Celecoxib Generic | 78 | 167 | 29 | $3,426 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 68 | 68 | 11 | $1,146 |
| Prolia Denosumab | 53 | 316 | 35 | $91K |
Brand drugs: 364 claims; generic drugs: 2,789 claims; opioid claims: 196.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jordan E Brodsky $4,954 ($4,954 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $1,137.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $1,137 |
| Amgen Inc. AMGN | 49 | $975 |
| Janssen Biotech, Inc. JNJ | 30 | $592 |
| UCB, Inc. UCB.BR | 28 | $429 |
| Novartis Pharmaceuticals Corporation NVS | 24 | $363 |
| Pfizer Inc. PFE | 17 | $351 |
| GlaxoSmithKline, LLC. GSK | 11 | $309 |
| Mallinckrodt Hospital Products Inc. | 9 | $235 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $173 |
| Aurinia Pharma U.S., Inc. AUPH | 7 | $130 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.